Selectivity for full AAV capsids in affinity capture with camelid ligands
Journal of Chromatography A · 2026-01 · 1767 · 466644
DOI: 10.1016/j.chroma.2025.466644 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Chromatography A, 2026-01. Verfasst von Lukas Bongers und 8 weiteren Autor:innen. Beteiligte Einrichtung: Gene Therapy Technical Research & Development, Roche Diagnostics GmbH, 82377 Penzberg, Germany. Electronic address: lukas.bongers@roche.com. Hauptthemen laut MEDLINE: Dependovirus, Chromatography, Affinity, Capsid, Capsid Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The industry standard for downstream processing of adeno-associated viral vectors (AAV) is purification by affinity capture and anion exchange polishing (AEX). Affinity capture is an attractive method for capturing AAVs as it can remove process-related impurities and selectively enrich AAVs. Full capsids are then separated on AEX-resin from product related impurities based on net surface charge. Enrichment of full capsids remains a big challenge, as biophysical properties of full and empty capsids are very similar. We present a novel approach to enrich full capsids during capture chromatography using affinity resins. We examined the impact of additives (NaCl, MgCl2, Na2SO4), NaCl concentrations (0 - 1000 mM), temperature and different affinity ligands (POROS™ CaptureSelect™ AAVX, AAV8, AAV9; CaptoAVB and AVIPure AAV8). We tested our approach for the serotypes AAV8 wild type (WT), AAV9 WT and an rAAV2 derivative and demonstrated 2.5-fold full capsid enrichment in a robotic screening. Analyzing an elution peak in fine increments yielded in multiple fractions approaching 100% full capsids. While several affinity resins demonstrated full capsid selectivity, we report that AAVX achieved the highest resolution. The selectivity was then linked to the affinity ligands specific binding mechanism towards an AAV capsid. This novel capture method offers a trade-off between full capsid yield and purity without the need for additional unit operations while using an already established process. With enriched loading material for the subsequent anion exchange step, the polished elution pool has a higher full-to-total ratio (FTR) compared to a process based on standard affinity capture conditions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Gene Therapy Technical Research & Development, Roche Diagnostics GmbH, 82377 Penzberg, Germany. Electronic address: lukas.bongers@roche.com.
- Roche Pharma Research and early Development, Roche Innovation Center Basel, Hoffmann-La Roche Ltd., 4070 Basel, Switzerland.
- Gene Therapy Technical Research & Development, Roche Diagnostics GmbH, 82377 Penzberg, Germany.
- Department of Biomolecular Separation Engineering, Karlsruhe Institute of Technology, 76131 Karlsruhe, Germany.
Zitieren
APA
Bongers, L., Franken, L. E., Hoch, D., Huber, V. E., Öttl, V., Raaf, E. B., Hubbuch, J., Falkenstein, R., & Martinez, A. D. (2026). Selectivity for full AAV capsids in affinity capture with camelid ligands. Journal of Chromatography A, 1767, 466644. https://doi.org/10.1016/j.chroma.2025.466644
Vancouver
Bongers L, Franken LE, Hoch D, Huber VE, Öttl V, Raaf EB, et al. Selectivity for full AAV capsids in affinity capture with camelid ligands. Journal of Chromatography A. 2026;1767:466644. doi:10.1016/j.chroma.2025.466644
BibTeX
@article{Bongers2026,
author = {Bongers, Lukas and Franken, Linda E and Hoch, Dominik and Huber, Veronika E and Öttl, Veronika and Raaf, Elena B and Hubbuch, Jürgen and Falkenstein, Roberto and Martinez, Andres D},
title = {Selectivity for full AAV capsids in affinity capture with camelid ligands},
journal = {Journal of Chromatography A},
year = {2026},
volume = {1767},
pages = {466644},
doi = {10.1016/j.chroma.2025.466644}
}
EUVIMED